The Ambiotis news

A new model of IBD

As part of its research, Ambiotis announces promising results on a model of IBD and intestinal irritation to evaluate pro-resolving compounds.  The model presents a specific metabolipidomic signature that contains immunoresolvent molecules. 

This model will thus represent a tool of choice to test compounds that act on intestinal permeability and inflammation and that aim to restore a good intestinal balance thanks to the mobilization of resolutive pathways.

More Informations

Where to meet with Ambiotis in 2018

Ambiotis will attend the following events :

Keystone symposium : The Resolution of Inflammation in Health and Disease - March 24-28, 2018 – Dublin, Ireland

1st Resolution days : The resolution of inflammation, opportunities for innovative therapeutics ? - April 4-6, 2018 - Besançon, France

In Cosmetics - April 17-19, 2018 – Amsterdam, Netherlands

Vitafoods Europe - May 15-17, 2018 - Geneva, Switzerland

International Investigative Dermatology Meeting - May 16-19, 2018 - Orlando, United States

The New York Academy of Sciences : Resolution of Inflammation, Infection and Tissue Regeneration - June 25-26, 2018 - New York, United States

7th European Workshop on Lipid Mediators - September 12-14, 2018 - Brussels, Belgium

30th IFSCC congress - September 18-21, 2018 - Munich, Germany

Book a meeting